Rapid Micro Biosystems Q4 Earnings Call Highlights

Rapid Micro Biosystems (NASDAQ: RPID) reported fourth-quarter and full-year 2025 results highlighting record quarterly revenue, increased system placements, and expanding recurring revenue, while also outlining expectations for revenue growth and gross margin improvement in 2026. Fourth-quarter results set revenue and placement records Management said fourth-quarter revenue rose 37% year-over-year to a quarterly record of $11.3 million,